Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Radl, Daniela Betiana ^a   Ferraris, Jimena ^a   Boti, Valeria ^a   Seilicovich, Adriana ^a   Sarkar, Dipak Kumar ^b   Pisera, Daniel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; ESTRADIOL; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; CABERGOLINE; ERGOLINE DERIVATIVE; PROTEIN KINASE INHIBITOR;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL STRAIN; CELL STRAIN PR1 D2S; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; FEMALE; NONHUMAN; PROLACTIN SECRETING CELL; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; WISTAR RAT;

RATTUS;

ANIMALS; APOPTOSIS; DOPAMINE; ERGOLINES; ESTRADIOL; FEMALE; LACTOTROPHS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2;

EID: 79953047753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018097     Document Type: Article

References (42)

1. Ben-Jonathan N, Hnasko R, (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22: 724-763.
2. Radl DB, Zárate S, Jaita G, Ferraris J, Zaldivar V, et al. (2008) Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent. Neuroendocrinology 88: 43-52.
3. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG, (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
4. Guiramand J, Montmayeur JP, Ceraline J, Bhatia M, Borrelli E, (1995) Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem 270: 7354-7358.
5. Senogles SE, (1994) The D2 Dopamine Receptor Isoforms Signal through Distinct Gi, Proteins to Inhibit Adenylyl Cyclase. J Biol Chem 269: 23120-23127.
6. Montmayeur JP, Borrelli E, (1991) Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci U S A 88: 3135-3139.
7. Guivarc'h D, Vernier P, Vincent JD, (1995) Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain. Neuroscience 69: 159-166.
8. Guivarc'h D, Vincent JD, Vernier P, (1998) Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 139: 4213-4221.
9. Oomizu S, Boyadjieva N, Sarkar DK, (2003) Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Alcohol Clin Exp Res 27: 975-980.
10. Gillam MP, Molitch ME, Lombardi G, Colao A, (2006) Advances in the treatment of prolactinomas. Endocr Rev 27: 485-534.
11. Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, et al. (1995) Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies. Endocr J 42: 413-420.
12. Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, et al. (1995) In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors. Endocr J 42: 153-161.
13. Passos VQ, Fortes MA, Giannella-Neto D, Bronstein MD, (2009) Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists. Neuroendocrinology 89: 163-170.
14. Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, et al. (1994) Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas. Neuroendocrinology 60: 314-322.
15. Wu ZB, Zheng WM, Su ZP, Chen Y, Wu JS, et al. (2010) Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior. J Neurooncol 99: 25-32.
16. Candolfi M, Zaldivar V, De Laurentiis A, Jaita G, Pisera D, et al. (2002) TNF-alpha induces apoptosis of lactotropes from female rats. Endocrinology 143: 3611-3617.
17. Jaita G, Candolfi M, Zaldivar V, Zarate S, Ferrari L, et al. (2005) Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes. Endocrinology 146: 4737-4744.
18. Bonci A, Hopf FW, (2005) The dopamine D2 receptor: new surprises from an old friend. Neuron 47: 335-338.
19. Eusung J, Mouradian M, (2001) Apoptotic signalling in dopamine-induce cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. Journal of Neurochemistry 78: 374-383.
20. An JJ, Cho SR, Jeong DW, Park KW, Ahn YS, et al. (2003) Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. Mol and Cell Endocrinol 206: 49-62.
21. Hashi A, Mazawa S, Chen SY, Yamakawa K, Kato J, et al. (1996) Estradiol-induced diurnal changes in lactotroph proliferation and their hypothalamic regulation in ovariectomized rats. Endocrinology 137: 3246-3252.
22. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK, (1995) Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res 55: 4892-4898.
23. Sarkar DK, Chaturvedi K, Oomizu S, Boyadjieva NI, Chen CP, (2005) Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology 146: 4179-4188.
24. Pisera D, Candolfi M, Navarra S, Ferraris J, Zaldivar V, et al. (2004) Estrogens sensitize anterior pituitary gland to apoptosis. Am J Physiol Endocrinol Metab 287: 767-771.
25. Hnasko TS, Hnasko RM, Sotak BN, Kapur RP, Palmiter RD, (2007) Genetic disruption of dopamine production results in pituitary adenomas and severe prolactinemia. Neuroendocrinology 86: 48-57.
26. Saiardi A, Bozzi Y, Baik JH, Borrelli E, (1997) Antiproliferative role of dopamine: loss of D2 receptor causes hormonal dysfunction and pituitary hyperplasia. Neuron 19: 115-126.
27. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, et al. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19: 103-113.
28. De Mei C, Ramos M, Iitaka C, Borrelli E, (2009) Getting specialized: presynaptic and postsynaptic dopamine D2 Receptor. Curr Opin Pharmacol 9: 53-58.
29. Xua A, Parlow AF, Wang Y, (2002) The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor. Brain Research 939: 95-99.
30. Iaccarino C, Samad TA, Mathis C, Kercret H, Picetti R, et al. (2002) Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs. Proc Natl Acad Sci U S A 99: 14530-14535.
31. Takeuchi Y, Fukunaga K, (2003) Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells. J Neurochem 85: 1064-1074.
32. McChesney R, Sealfon SC, Tsutsumi M, Dong KW, Roberts JL, et al. (1991) Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter. Mol Cell Endocrinol 79: R1-R7.
33. Choi EY, Jeong D, Park KW, Baik JH, (1999) G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors. Biochem Biophys Res Commun 256: 33-40.
34. Van-Ham II, Banihashemi B, Wilson AM, Jacobsen KX, Czesak M, et al. (2007) Differential signaling of dopamine-D2S and-D2L receptors to inhibit ERK1/2 phosphorylation. J Neurochem 102: 1796-1804.
35. Colao A, (2009) Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab 23: 575-596.
36. Zatelli MC, Minoia M, Filieri C, Tagliati F, Buratto M, et al. (2009) Effect of everolimus on cell viability in nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 95: 968-976.
37. Hofland LJ, Feelders RA, de Herder WW, Lamberts SW, (2010) Pituitary tumours: the sst/D2 receptors as molecular targets. Mol Cell Endocrinol 326: 89-98.
38. Choi WS, Eom DS, Han BS, Kim WK, Han BH, et al. (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and-9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 279: 20451-20460.
39. Zaldivar V, Magri ML, Zárate S, Jaita G, Eijo G, et al. (2009) Estradiol increases the Bax/Bcl-2 ratio and induces apoptosis in the anterior pituitary gland. Neuroendocrinology 90: 292-300.
40. Ying C, (2000) Potential involvement of tumor suppressor gene expression in the formation of estrogen-inducible pituitary tumors in rats. Endocr J 47: 1-5.
41. Wu GS, (2004) The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 3: 156-161.
42. Molitch ME, (2008) The Cabergoline-Resistant Prolactinoma Patient: New Challenges. J Clin Endocrinol Metab 93: 4643-4645.